Carbidopa

규격

28860-95-9CAS 번호

249-271-9EC 번호

(2S)-3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoic acidIUPAC 명칭

C10H14N2O4화학식

226.23 g/mol분자량

carbidopa; 28860-95-9; Lodosyn; Carbidopa anhydrous; (S)-carbidopa; (S)-(-)-carbidopa; N-Aminomethyldopa; alpha-Methyldopahydrazine; Carbidopum; L-alpha-Methyldopahydrazine; Carbidopa (anhydrous); (2S)-3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoic acid; MK 486; L-3-(3,4-Dihydroxyphenyl)-2-methyl-2-hydrazinopropionic acid; DTXSID4022735; (-)-L-alpha-Hydrazino-3,4-dihydroxy-alpha-methylhydrocinnamic acid; KR87B45RGH; MK-486; (alphaS)-alpha-hydrazino-3,4-dihydroxy-alpha-methylbenzenepropanoic acid; DTXCID502735; CHEBI:39585; (-)-L-alpha-Hydrazino-3,4-dihydroxy-alpha-methylhydrocinnamic acid monohydrate; Benzenepropanoic acid, alpha-hydrazino-3,4-dihydroxy-alpha-methyl-, (S)-; Carbidopum monohydrate; NSC-751137; CHEBI:3395; Methyldopahydrazine; DHIVY COMPONENT CARBIDOPA; DUOPA COMPONENT CARBIDOPA; RYTARY COMPONENT CARBIDOPA; CREXONT COMPONENT CARBIDOPA; STALEVO COMPONENT CARBIDOPA; CORBILTA COMPONENT CARBIDOPA; NSC-758190; MK485; Carbidopa Tablets; LEVODOPA/CARBIDOPA/ENTACAPONE ORION COMPONENT CARBIDOPA; L-Carbidopa Anhydrous; RefChem:918027; Carbidopa Tablets, 25 mg; MK486; (2S)-2-(azaniumylamino)-3-(3,4-dihydroxyphenyl)-2-methylpropanoate; Benzenepropanoic Acid, alpha-hydrazino-3,4-dihydroxy-alpha-methyl-,(S)-; 249-271-9; 657-445-4; (2S)-3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoic acid hydrate; Benzenepropanoic acid, alpha-hydrazino-3,4-dihydroxy-alpha-methyl-, monohydrate, (S)-; MNX7R8C5VO; S-(-)-Carbidopa; Carbidopum [INN-Latin]; S(-)-CARBIDOPA; (S)-3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoic acid; Carbidopa [INN]; MFCD00069231; (2S)-3-(3,4-dihydroxyphenyl)-2-hydrazino-2-methylpropanoic acid; CARBIDOPA, L- ANHYDROUS; NCGC00024596-05; (2S)-3-(3,4-dihydroxyphenyl)-2-hydrazino-2-methyl-propanoic acid; Hadrazino-alpha-methyldopa; alpha-Hydrazino-alpha-methyl-beta-(3,4-dihydroxyphenyl)propionic acid; C-DOPA; 3,3,3-trideuterio-2-[dideuterio-(3,4-dihydroxyphenyl)methyl]-2-hydrazinylpropanoic acid; SMR000058235; CCRIS 5093; SR-01000597655; EINECS 249-271-9; UNII-KR87B45RGH; Neo-Dopaston; Lodosyn;; Lodysin;; Menesit;; Benzenepropanoic acid, .alpha.-hydrazino-3,4-dihydroxy-.alpha.-methyl-, (S)-; 28860-95-9 (anhydrous); L-alpha-Methyl-alpha-hydrazino-beta-(3,4-dihydroxyphenylpropionic acid; L-alpha-Methyl-beta-(3,4-dihydroxyphenyl)-alpha-hydrazinopropionic acid; ND0611; Tocris-0455; C-126; CARBIDOPA [WHO-DD]; Lopac0_000382; SCHEMBL35084; MLS000069628; MLS002207014; GTPL5159; orb1225420; orb1300458; CARBIDOPA ANHYDROUS [MI]; CHEMBL1201236; SCHEMBL29392554; GLXC-06131; HMS2089B12; HMS3266A20; HMS3411M13; HMS3655G20; HMS3675M13; HMS3713L10; HMS3884M14; HY-B0311; Tox21_110910; BDBM50418773; EBC-01053; NSC751137; s1891; SBB000659; AKOS015969657; HYDROCINNAMIC ACID, alpha-HYDRAZINO-3,4-DIHYDROXY-alpha-METHYL-, L-; AC-1676; CCG-204476; DB00190; SDCCGMLS-0072919.P025; MLS-0072919; SMP1_000057; NCGC00024596-01; NCGC00024596-03; NCGC00024596-06; NCGC00024596-07; NCGC00024596-08; AS-16862; BC164279; ST055523; MLS-0072919.P013; CAS-28860-95-9; C2450; EU-0100382; NS00005042; SW199080-2; T6795; AB00441332-05; AB00441332-06; AB00441332_07; AB00441332_08; EN300-6733817; F869032; SR-01000597655-1; SR-01000597655-3; SR-01000597655-5; SR-01000597655-9; BRD-K78712176-001-07-5; BRD-K78712176-001-11-7; BRD-K78712176-001-12-5; BRD-K78712176-001-13-3; BRD-K78712176-001-14-1; Z2301684895; (S)-3-(3,4-dihydroxyphenyl)-2-hydrazineyl-2-methylpropanoic acid; (S)-3-(3,4-Dihydroxyphenyl)-2-hydrazino-2-methylpropionic Acid; (S)-3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoicacid; (2S)-3-(3,4-dihydroxyphenyl)-2-hydrazino-2-methylpropionic acid monohydrate; Benzenepropanoic acid, .alpha.-hydrazinyl-3,4-dihydroxy-.alpha.-methyl-, (.alpha.S)-; KINSON; 3-(3,4-DIHYDROXY-PHENYL)-2-HYDRAZINO-2-METHYL-PROPIONIC ACID; 1426847-87-1동의어